Different contribution of apoptosis to the antiproliferative effects of L-arginine, enalapril and losartan on neointimal growth inhibition after balloon arterial injury

Circulation Journal

Volumn 66, Issue 10, 2002, Pages 965-971

  Ohwada, Takayuki ^a   Ishibashi, Toshiyuki ^a   Yaoita, Hiroyuki ^a   Shindo, Joji ^a   Noji, Hideyoshi ^a   Ohkawara, Hiroyuki ^a   Sugimoto, Kouichi ^a   Sakamoto, Takayuki ^a   Maehara, Kazuhira ^a   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

ACE inhibitor; Apoptosis; Atherosclerosis; Nitric oxide; Restenosis

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ARGININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INDUCIBLE NITRIC OXIDE SYNTHASE; LOSARTAN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; UNCLASSIFIED DRUG; NOS2 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY INTIMA; ARTERY MEDIA; ARTERY MUSCLE; ARTICLE; CAROTID ARTERY INJURY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ANALYSIS; MALE; NICK END LABELING; NONHUMAN; OSMOTIC PUMP; RAT; ANIMAL; BALLOON DILATATION; BIOSYNTHESIS; CELL DIVISION; COMPARATIVE STUDY; ENZYMOLOGY; GRAFT OCCLUSION; PATHOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; APOPTOSIS; ARGININE; BALLOON DILATATION; CAROTID ARTERY INJURIES; CELL DIVISION; ENALAPRIL; GRAFT OCCLUSION, VASCULAR; LOSARTAN; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 19044390790     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.965     Document Type: Article

References (30)

1. Powell JS, Clozel JP, Muller RK, Kuhn H, Hefti F, Hosang M, et al. Inhibitors of angiotensin-converting enzyme prevent neointimal proliferation after vascular injury. Science 1989; 245: 186-188.
2. Faxon DP. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: Final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group. J Am Coll Cardiol 1995; 25: 362-369.
3. Linz W, Wiemer G, Scholkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol 1993; 22(Suppl 9): S1-S8.
4. Lamontagne D, Konig A, Bassenge E, Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol 1992; 20: 652-657.
5. Farhy RD, Carretero OA, Ho KL, Scicli AG. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 1993; 72: 1202-1210.
6. Geng YJ, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol 1996; 16: 19-27.
7. Nishio E, Fukushima K, Shiozaki M, Watanabe Y. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem Biophys Res Commun 1996; 221: 163-168.
8. Mallat Z, Heymes C, Ohan J, Faggin E, Leseche G, Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol 1999; 19: 611-616.
9. Iwashina M, Shichiri M, Marumo F, Hirata Y. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells. Circulation 1998; 98: 1212-1218.
10. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmouliere A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol 1995; 146: 1059-1064.
11. Tea BS, Der Sarkissian S, Touyz RM, Hamet P, deBlois D. Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneous hypertensive rats in vivo. Hypertension 2000; 35: 1069-1073.
12. Prescott MF, Webb RL, Reidy MA. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist: Effects on smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol 1991; 139: 1291-1296.
13. Bachmaier K, Neu N, Pummerer C, Duncan G, Mark T, Matsuyama T, Penninger JM. iNOS expression and nitrotyrosine formation in the myocardium in response to inflammation is controlled by the interferon regulatory transcription factor 1. Circulation 1997; 96: 585-591.
14. Higman DJ, Strachan AM, Buttery L, Hicks RC, Springall DR, Greenhalgh RM, et al. Smoking impairs the activity of endothelial nitric oxide synthase in saphenous vein. Arterioscler Thromb Vasc Biol 1996; 16: 546-552.
15. Yokoyama K, Ishibashi T, Ohkawara H, Kimura J, Matsuoka I, Sakamoto T, et al. HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells. Circulation 2002; 105: 962-967.
16. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
17. Imanishi T, Hano T, Nishio I, Han DK, Schwartz SM. Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from endothelial cells. Jpn Circ J 2001; 65: 556-560.
18. Holm AM, Andersen CB, Haunso S, Hansen PR. Effects of L-arginine on vascular smooth muscle cell proliferatrion and apoptosis after balloon injury. Scand Cardiovasc J 2000; 34: 28-32.
19. Yamada T, Akishita M, Pollman MJ, Gibbons GH, Dzau VJ, Horiuchi M. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: An in vitro gene transfer study. Life Sci 1998; 63: PL289-PL295.
20. Holm AM, Andersen CB, Haunso S, Hansen PR. ACE-inhibition promotes apoptosis after balloon injury of rat carotid arteries. Cardiovasc Res 2000; 45: 777-782.
21. Tiffany CW, Burch RM. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett 1989; 247: 189-192.
22. Vandekerckhove F, Opdenakker G, Van Ranst M, Lenaerts JP, Put W, Billiau A. et al. Bradykinin induces interleukin-6 and synergizes with interleukin-1. Lymphokine Cytokine Res 1991; 10: 285-289.
23. Joly GA, Schini VB, Vanhoutte PM. Balloon injury and interleukin-1 beta induce nitric oxide synthase activity in rat carotid arteries. Circ Res 1992; 71: 331-338.
24. Yasuda M, Umemura S, Osamura RY, Kenjo T, Tsutsumi Y. Apoptotic cells in the human endometrium and placental villi: Pitfalls in applying the TUNEL method. Arch Histol Cytol 1995; 58: 185-190.
25. Kato S, Takemura G, Maruyama R, Aoyama T, Hayakawa K, Koda M, et al. Apoptosis, rather than oncosis, is the predominant mode of spontaneous death of isolated adult rat cardiac myocytes in culture. Jpn Circ J 2001; 65: 743-748.
26. Kanoh M, Takemura G, Misao J. Hayakawa Y, Aoyama T, Nishigaki K, et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: Not apoptosis but DNA repair. Circulation 1999; 99: 2757-2764.
27. Kockx MM, Muhring J, Knaapen MW, de Meyer GR. RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am J Pathol 1998; 152: 885-888.
28. Han DK, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995; 147: 267-277.
29. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 1983; 49: 327-333.
30. deBlois D, Tea BS, Than VD, Tremblay J, Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 1997; 29: 340-349.